Reacción #91250

ord-6700a5250b074844827f60ef1b1f373f

Condiciones de reacción

Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    Otroto react sequentially in the same manner as in Steps A and B of Example 1

Procedimiento

3-Chloromethyl-2-isopropylsulfanyl-pyridine (33 mg, 0.16 mmol) obtained in Step C of Preparation Example 1 and 2-(3-chloro-4-hydroxy-phenyl)-cyclopropane carboxylic acid ethyl ester (43 mg, 0.17 mmol) obtained in Step B of Preparation Example 47 were used to react sequentially in the same manner as in Steps A and B of Example 1 to obtain the title compound (42 mg, 80%).

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US09447044B2uspto-grants-2016_09